Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
Explore this paper's citation graph
Summary
FibroScan is a simple and effective method for assessing liver fibrosis, with similar performance to FibroTest and APRI, and could avoid a biopsy procedure in most patients with chronic hepatitis C.
- Type
- article
- Published
- 2005-02-01
- Cited by
- 2,855
- References
- 37
- Access
- Open access
- OpenAlex
- https://openalex.org/W2027498662
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:42078568
Keywords
Medicine, Transient elastography, Liver biopsy, Receiver operating characteristic, Gastroenterology
References
- One-second biopsy of the liver--problems of its clinical application.
- Biochemical Markers of Fibrosis in Patients with Chronic Hepatitis C: A Comparison with Prothrombin Time, Platelet Count, and Age–Platelet Index
- Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
- Expression of Granzyme B in viral hepatitis in patients with ALPS
- Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa‐2b and ribavirin
- Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
- Noninvasive diagnosis of hepatic fibrosis or cirrhosis.
- Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
- 68 Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C
- Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.
- Sampling variability of liver fibrosis in chronic hepatitis C
- Noninvasive prediction of fibrosis in patients with chronic hepatitis C
- Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?
- Role of liver biopsy in management of chronic hepatitis C: A systematic review
- Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C
- Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients.
- Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C
- Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
Cited by
- Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy
- The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations.
- Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
- Influence of perfusion on hepatic MR diffusion measurement
- Evaluation of hepatic lesions and hepatic parenchyma using diffusion‐weighted echo‐planar MR with three values of gradient b‐factor
- Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases
- Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C.
- Dynamic analysis of EUS used for the differentiation of benign and malignant lymph nodes.
- Screening for esophageal varices: Endoscopy, other tools, or endoscopy and other tools?
- Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases.
- Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients
- IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus‐/HCV‐coinfected patients
- Primary Sclerosing Cholangitis: Current and Future Management Strategies
- Transient elastography: Kill two birds with one stone?
- ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study.
- Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
- Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis
- Point shear wave elastography method for assessing liver stiffness.
- Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C.
- The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
Related papers
- How Often Does Liver Fibrosis Stage Predicted by Transient Elastography (TE) Differ From the One Diagnosed by Liver Biopsy in Chronic Hepatitis C Patients
- Transient Elastography with Serum Hepatitis B Surface Antigen Enhances Liver Fibrosis Detection
- Transient elastography--an alternative to liver biopsy in patients with chronic hepatitis C?
- Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible.
- How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
- Noninvasive Estimation of Hepatic Steatosis by Controlled Attenuation Parameter in Living Donor Liver Transplant.
- A sequential predictive algorithm combining APRI and transient elastography for diagnosing liver fibrosis in chronic hepatitis C
- Non-invasive assessment of the liver fibrosis by transient elastography (TE) in patients with transfusion-dependent thalassemia
- Liver Transient Elastography (Fibroscan®): A Place in the Management Algorithms of Chronic Viral Hepatitis